{
  "solution_stats": {
    "total_solutions": 7,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 4
      },
      {
        "solution_id": 2,
        "steps_count": 4
      },
      {
        "solution_id": 3,
        "steps_count": 5
      },
      {
        "solution_id": 4,
        "steps_count": 7
      },
      {
        "solution_id": 5,
        "steps_count": 7
      },
      {
        "solution_id": 6,
        "steps_count": 7
      },
      {
        "solution_id": 7,
        "steps_count": 9
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule39",
              "prover9": "(-(-(-G -> -A1) -> A2) -> A4)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> market_authorization(compound_x))",
              "natural": "Whenever it is not the case that if it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X receives market authorization."
            },
            {
              "id": "Rule20",
              "prover9": "(A4 -> A3)",
              "prover9_expression": "(market_authorization(compound_x) -> regulatory_approval(compound_x))",
              "natural": "If compound X receives market authorization, then compound X obtains regulatory approval."
            }
          ],
          "conclusion": "(-(-(-G -> -A1) -> A2) -> A3)",
          "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-(-G -> -A1) -> A2) -> A3)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> regulatory_approval(compound_x))",
              "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
            },
            {
              "id": "Rule40",
              "prover9": "(-(-(-G -> -A1) -> A2) -> -A3)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> -regulatory_approval(compound_x))",
              "natural": "Under the condition that it is not the case that provided that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X does not obtain regulatory approval."
            }
          ],
          "conclusion": "(-(-G -> -A1) -> A2)",
          "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-G -> -A1) -> A2)",
              "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x))",
              "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
            },
            {
              "id": "Rule41",
              "prover9": "(-(-G -> -A1) -> -A2)",
              "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> -clinical_trial_success(compound_x))",
              "natural": "Provided that it is not the case that if compound X is not profitable then compound X is not approved for research, compound X does not have clinical trial success."
            }
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule43",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-profitable_product(compound_x) -> approved_for_research(compound_x))",
              "natural": "If compound X is not profitable, then compound X is approved for research."
            },
            {
              "id": "Derived",
              "prover9": "(-G -> -A1)",
              "prover9_expression": "(-profitable_product(compound_x) -> -approved_for_research(compound_x))",
              "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule2",
              "prover9": "(A10 | A11)",
              "prover9_expression": "(quality_test_failure(batch_z) | contamination_detected(batch_z))",
              "natural": "Either batch Z fails quality testing or contamination is detected in batch Z."
            },
            {
              "id": "Rule1",
              "prover9": "(A10 -> (A8 | A9))",
              "prover9_expression": "(quality_test_failure(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
              "natural": "If batch Z fails quality testing, then either excipient Y experiences raw material shortage or excipient Y experiences supplier delay."
            },
            {
              "id": "Rule3",
              "prover9": "(A11 -> (A8 | A9))",
              "prover9_expression": "(contamination_detected(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
              "natural": "Provided that contamination is detected in batch Z, it follows that either excipient Y has raw material shortage or excipient Y has supplier delay."
            }
          ],
          "conclusion": "(A8 | A9)",
          "natural": "Either excipient Y has raw material shortage or excipient Y has supplier delay."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(raw_material_shortage(excipient_y) | supplier_delay(excipient_y))",
              "natural": "Either excipient Y has raw material shortage or excipient Y has supplier delay."
            },
            {
              "id": "Rule28",
              "prover9": "(A8 -> -A7)",
              "prover9_expression": "(raw_material_shortage(excipient_y) -> -supply_chain_issue(compound_x))",
              "natural": "If excipient Y has raw material shortage, then compound X does not experience supply chain issues."
            },
            {
              "id": "Rule29",
              "prover9": "(A9 -> -A7)",
              "prover9_expression": "(supplier_delay(excipient_y) -> -supply_chain_issue(compound_x))",
              "natural": "Provided that excipient Y has supplier delay, compound X does not experience supply chain issues."
            }
          ],
          "conclusion": "-A7",
          "natural": "Compound X does not experience supply chain issues."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule27",
              "prover9": "(A7 | (A5 -> G))",
              "prover9_expression": "(supply_chain_issue(compound_x) | (production_scale_up(compound_x) -> profitable_product(compound_x)))",
              "natural": "Either compound X experiences supply chain issues or if compound X undergoes production scale-up then compound X is profitable."
            },
            {
              "id": "Derived",
              "prover9": "-A7",
              "prover9_expression": "-supply_chain_issue(compound_x)",
              "natural": "Compound X does not experience supply chain issues."
            }
          ],
          "conclusion": "(A5 -> G)",
          "natural": "If compound X undergoes production scale-up, then compound X is profitable."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule25",
              "prover9": "(A5 | A6)",
              "prover9_expression": "(production_scale_up(compound_x) | manufacturing_optimization(compound_x))",
              "natural": "Either compound X undergoes production scale-up or compound X undergoes manufacturing optimization."
            },
            {
              "id": "Derived",
              "prover9": "(A5 -> G)",
              "prover9_expression": "(production_scale_up(compound_x) -> profitable_product(compound_x))",
              "natural": "If compound X undergoes production scale-up, then compound X is profitable."
            },
            {
              "id": "Rule26",
              "prover9": "(A6 -> G)",
              "prover9_expression": "(manufacturing_optimization(compound_x) -> profitable_product(compound_x))",
              "natural": "Whenever compound X undergoes manufacturing optimization, compound X becomes profitable."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule8",
              "prover9": "(A17 | A18)",
              "prover9_expression": "(quality_control_inspection(plant_a) | audit_finding(plant_a))",
              "natural": "Either plant A undergoes quality control inspection or plant A has audit findings."
            },
            {
              "id": "Rule7",
              "prover9": "(A17 -> (-(A14 -> (A12 | G)) -> A16))",
              "prover9_expression": "(quality_control_inspection(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
              "natural": "Provided that plant A undergoes quality control inspection, if it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
            },
            {
              "id": "Rule9",
              "prover9": "(A18 -> (-(A14 -> (A12 | G)) -> A16))",
              "prover9_expression": "(audit_finding(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
              "natural": "Whenever plant A has audit findings, if it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
            }
          ],
          "conclusion": "(-(A14 -> (A12 | G)) -> A16)",
          "natural": "Whenever it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is rejected."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A14 -> (A12 | G)) -> A16)",
              "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z))",
              "natural": "Whenever it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is rejected."
            },
            {
              "id": "Rule6",
              "prover9": "(A16 -> A15)",
              "prover9_expression": "(batch_rejection(batch_z) -> product_recall(batch_z))",
              "natural": "If batch Z is rejected, then batch Z is subject to product recall."
            }
          ],
          "conclusion": "(-(A14 -> (A12 | G)) -> A15)",
          "natural": "If it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is subject to product recall."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A14 -> (A12 | G)) -> A15)",
              "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> product_recall(batch_z))",
              "natural": "If it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is subject to product recall."
            },
            {
              "id": "Rule30",
              "prover9": "(-(A14 -> (A12 | G)) -> -A15)",
              "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> -product_recall(batch_z))",
              "natural": "Provided that it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is not subject to product recall."
            }
          ],
          "conclusion": "(A14 -> (A12 | G))",
          "natural": "Under the condition that formulation W undergoes real-time stability testing, either formulation W passes stability study or compound X is profitable."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A13 | A14)",
              "prover9_expression": "(accelerated_aging_test(formulation_w) | real_time_stability(formulation_w))",
              "natural": "Formulation W undergoes accelerated aging testing or formulation W undergoes real-time stability testing."
            },
            {
              "id": "Rule4",
              "prover9": "(A13 -> (A12 | G))",
              "prover9_expression": "(accelerated_aging_test(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
              "natural": "Whenever formulation W undergoes accelerated aging testing, either formulation W passes stability study or compound X becomes profitable."
            },
            {
              "id": "Derived",
              "prover9": "(A14 -> (A12 | G))",
              "prover9_expression": "(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
              "natural": "Under the condition that formulation W undergoes real-time stability testing, either formulation W passes stability study or compound X is profitable."
            }
          ],
          "conclusion": "(A12 | G)",
          "natural": "Formulation W passes stability study or compound X is a profitable product."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 | G)",
              "prover9_expression": "(stability_study_pass(formulation_w) | profitable_product(compound_x))",
              "natural": "Formulation W passes stability study or compound X is a profitable product."
            },
            {
              "id": "Fact1",
              "prover9": "-A12",
              "prover9_expression": "-stability_study_pass(formulation_w)",
              "natural": "Formulation W does not pass stability study."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule14",
              "prover9": "(A26 -> A24)",
              "prover9_expression": "(validation_protocol(manufacturing_line_b) -> process_validation(manufacturing_line_b))",
              "natural": "If manufacturing line B has validation protocol, then manufacturing line B undergoes process validation."
            },
            {
              "id": "Rule16",
              "prover9": "(A27 -> A25)",
              "prover9_expression": "(qualification_study(manufacturing_line_b) -> equipment_qualification(manufacturing_line_b))",
              "natural": "Provided that manufacturing line B has qualification study, it follows that manufacturing line B has equipment qualification."
            },
            {
              "id": "Rule15",
              "prover9": "(A26 | A27)",
              "prover9_expression": "(validation_protocol(manufacturing_line_b) | qualification_study(manufacturing_line_b))",
              "natural": "Either manufacturing line B has validation protocol or manufacturing line B has qualification study."
            }
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A24 | A25)",
              "prover9_expression": "(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b))",
              "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
            },
            {
              "id": "Rule12",
              "prover9": "(A24 -> (-A22 -> A23))",
              "prover9_expression": "(process_validation(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
              "natural": "If manufacturing line B undergoes process validation, then provided that compound X does not undergo prior art search, compound X receives patent rejection."
            },
            {
              "id": "Rule13",
              "prover9": "(A25 -> (-A22 -> A23))",
              "prover9_expression": "(equipment_qualification(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
              "natural": "Whenever manufacturing line B has equipment qualification, if compound X does not undergo prior art search then compound X receives patent rejection."
            }
          ],
          "conclusion": "(-A22 -> A23)",
          "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A22 -> A23)",
              "prover9_expression": "(-prior_art_search(compound_x) -> patent_rejection(compound_x))",
              "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
            },
            {
              "id": "Rule42",
              "prover9": "(-A22 -> -A23)",
              "prover9_expression": "(-prior_art_search(compound_x) -> -patent_rejection(compound_x))",
              "natural": "Under the condition that compound X does not undergo prior art search, compound X does not receive patent rejection."
            }
          ],
          "conclusion": "A22",
          "natural": "Compound X undergoes prior art search."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(A22 -> (A21 -> A19))",
              "prover9_expression": "(prior_art_search(compound_x) -> (intellectual_property(compound_x) -> patent_protection(compound_x)))",
              "natural": "Under the condition that compound X undergoes prior art search, if compound X has intellectual property protection then compound X has patent protection."
            },
            {
              "id": "Derived",
              "prover9": "A22",
              "prover9_expression": "prior_art_search(compound_x)",
              "natural": "Compound X undergoes prior art search."
            }
          ],
          "conclusion": "(A21 -> A19)",
          "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A20 -> A21)",
              "prover9_expression": "(patent_filing(compound_x) -> intellectual_property(compound_x))",
              "natural": "Provided that compound X has patent filing, it follows that compound X has intellectual property protection."
            },
            {
              "id": "Derived",
              "prover9": "(A21 -> A19)",
              "prover9_expression": "(intellectual_property(compound_x) -> patent_protection(compound_x))",
              "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
            }
          ],
          "conclusion": "(A20 -> A19)",
          "natural": "If compound X has patent filing, then compound X has patent protection."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-G -> A20)",
              "prover9_expression": "(-profitable_product(compound_x) -> patent_filing(compound_x))",
              "natural": "Whenever compound X is not profitable, compound X has patent filing."
            },
            {
              "id": "Derived",
              "prover9": "(A20 -> A19)",
              "prover9_expression": "(patent_filing(compound_x) -> patent_protection(compound_x))",
              "natural": "If compound X has patent filing, then compound X has patent protection."
            }
          ],
          "conclusion": "(-G -> A19)",
          "natural": "Provided that compound X is not profitable, compound X has patent protection."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A19)",
              "prover9_expression": "(-profitable_product(compound_x) -> patent_protection(compound_x))",
              "natural": "Provided that compound X is not profitable, compound X has patent protection."
            },
            {
              "id": "Fact2",
              "prover9": "-A19",
              "prover9_expression": "-patent_protection(compound_x)",
              "natural": "Compound X does not have patent protection."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule33",
              "prover9": "(-(A30 | -A29) -> A31)",
              "prover9_expression": "(-(safety_profile(compound_x) | -efficacy_data(compound_x)) -> adverse_events(compound_x))",
              "natural": "Provided that it is not the case that either compound X has safety profile data or compound X does not have efficacy data, compound X has adverse events."
            },
            {
              "id": "Fact4",
              "prover9": "-A31",
              "prover9_expression": "-adverse_events(compound_x)",
              "natural": "Compound X does not have adverse events."
            }
          ],
          "conclusion": "(A30 | -A29)",
          "natural": "Either compound X has safety profile data or compound X does not have efficacy data."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A30 | -A29)",
              "prover9_expression": "(safety_profile(compound_x) | -efficacy_data(compound_x))",
              "natural": "Either compound X has safety profile data or compound X does not have efficacy data."
            },
            {
              "id": "Fact3",
              "prover9": "-A30",
              "prover9_expression": "-safety_profile(compound_x)",
              "natural": "Compound X does not have safety profile data."
            }
          ],
          "conclusion": "-A29",
          "natural": "Compound X does not have efficacy data."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule32",
              "prover9": "(-(A28 -> A3) -> A29)",
              "prover9_expression": "(-(phase_iii_completion(compound_x) -> regulatory_approval(compound_x)) -> efficacy_data(compound_x))",
              "natural": "If it is not the case that whenever compound X completes Phase III trials then compound X obtains regulatory approval, then compound X has efficacy data."
            },
            {
              "id": "Derived",
              "prover9": "-A29",
              "prover9_expression": "-efficacy_data(compound_x)",
              "natural": "Compound X does not have efficacy data."
            }
          ],
          "conclusion": "(A28 -> A3)",
          "natural": "Whenever compound X completes Phase III trials, compound X obtains regulatory approval."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule38",
              "prover9": "(-(-(-G -> -A1) -> A2) -> A28)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> phase_iii_completion(compound_x))",
              "natural": "If it is not the case that whenever it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, then compound X completes Phase III trials."
            },
            {
              "id": "Derived",
              "prover9": "(A28 -> A3)",
              "prover9_expression": "(phase_iii_completion(compound_x) -> regulatory_approval(compound_x))",
              "natural": "Whenever compound X completes Phase III trials, compound X obtains regulatory approval."
            }
          ],
          "conclusion": "(-(-(-G -> -A1) -> A2) -> A3)",
          "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-(-G -> -A1) -> A2) -> A3)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> regulatory_approval(compound_x))",
              "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
            },
            {
              "id": "Rule40",
              "prover9": "(-(-(-G -> -A1) -> A2) -> -A3)",
              "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> -regulatory_approval(compound_x))",
              "natural": "Under the condition that it is not the case that provided that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X does not obtain regulatory approval."
            }
          ],
          "conclusion": "(-(-G -> -A1) -> A2)",
          "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-G -> -A1) -> A2)",
              "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x))",
              "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
            },
            {
              "id": "Rule41",
              "prover9": "(-(-G -> -A1) -> -A2)",
              "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> -clinical_trial_success(compound_x))",
              "natural": "Provided that it is not the case that if compound X is not profitable then compound X is not approved for research, compound X does not have clinical trial success."
            }
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule43",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-profitable_product(compound_x) -> approved_for_research(compound_x))",
              "natural": "If compound X is not profitable, then compound X is approved for research."
            },
            {
              "id": "Derived",
              "prover9": "(-G -> -A1)",
              "prover9_expression": "(-profitable_product(compound_x) -> -approved_for_research(compound_x))",
              "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule36",
              "prover9": "(-(A37 | (A36 -> A34)) -> A38)",
              "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> packaging_redesign(compound_x))",
              "natural": "Provided that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X has packaging redesign."
            },
            {
              "id": "Rule37",
              "prover9": "(-(A37 | (A36 -> A34)) -> -A38)",
              "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> -packaging_redesign(compound_x))",
              "natural": "Under the condition that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X does not have packaging redesign."
            }
          ],
          "conclusion": "(A37 | (A36 -> A34))",
          "natural": "Either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A37 | (A36 -> A34))",
              "prover9_expression": "(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x)))",
              "natural": "Either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes."
            },
            {
              "id": "Fact5",
              "prover9": "-A37",
              "prover9_expression": "-shelf_life_extension(compound_x)",
              "natural": "Compound X does not have shelf life extension."
            }
          ],
          "conclusion": "(A36 -> A34)",
          "natural": "Whenever compound X has delivery system updates, compound X has formulation changes."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule19",
              "prover9": "(A35 -> A36)",
              "prover9_expression": "(excipient_modification(compound_x) -> delivery_system_update(compound_x))",
              "natural": "Provided that compound X has excipient modifications, compound X has delivery system updates."
            },
            {
              "id": "Derived",
              "prover9": "(A36 -> A34)",
              "prover9_expression": "(delivery_system_update(compound_x) -> formulation_change(compound_x))",
              "natural": "Whenever compound X has delivery system updates, compound X has formulation changes."
            }
          ],
          "conclusion": "(A35 -> A34)",
          "natural": "If compound X has excipient modifications, then compound X has formulation changes."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule34",
              "prover9": "(-(A32 | A33) -> A35)",
              "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> excipient_modification(compound_x))",
              "natural": "Whenever it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has excipient modifications."
            },
            {
              "id": "Derived",
              "prover9": "(A35 -> A34)",
              "prover9_expression": "(excipient_modification(compound_x) -> formulation_change(compound_x))",
              "natural": "If compound X has excipient modifications, then compound X has formulation changes."
            }
          ],
          "conclusion": "(-(A32 | A33) -> A34)",
          "natural": "Under the condition that it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has formulation changes."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A32 | A33) -> A34)",
              "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> formulation_change(compound_x))",
              "natural": "Under the condition that it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has formulation changes."
            },
            {
              "id": "Rule35",
              "prover9": "(-(A32 | A33) -> -A34)",
              "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> -formulation_change(compound_x))",
              "natural": "If it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, then compound X does not have formulation changes."
            }
          ],
          "conclusion": "(A32 | A33)",
          "natural": "Either pill form undergoes dissolution testing or pill form undergoes bioavailability study."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule17",
              "prover9": "(A32 -> A12)",
              "prover9_expression": "(dissolution_test(pill_form) -> stability_study_pass(formulation_w))",
              "natural": "If pill form undergoes dissolution testing, then formulation W passes stability study."
            },
            {
              "id": "Rule18",
              "prover9": "(A33 -> G)",
              "prover9_expression": "(bioavailability_study(pill_form) -> profitable_product(compound_x))",
              "natural": "Under the condition that pill form undergoes bioavailability study, compound X becomes profitable."
            },
            {
              "id": "Derived",
              "prover9": "(A32 | A33)",
              "prover9_expression": "(dissolution_test(pill_form) | bioavailability_study(pill_form))",
              "natural": "Either pill form undergoes dissolution testing or pill form undergoes bioavailability study."
            }
          ],
          "conclusion": "(A12 | G)",
          "natural": "Formulation W passes stability study or compound X is a profitable product."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 | G)",
              "prover9_expression": "(stability_study_pass(formulation_w) | profitable_product(compound_x))",
              "natural": "Formulation W passes stability study or compound X is a profitable product."
            },
            {
              "id": "Fact1",
              "prover9": "-A12",
              "prover9_expression": "-stability_study_pass(formulation_w)",
              "natural": "Formulation W does not pass stability study."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule23",
              "prover9": "(A41 | A42)",
              "prover9_expression": "(capa_implementation(manufacturing_line_b) | deviation_management(manufacturing_line_b))",
              "natural": "Either manufacturing line B has CAPA implementation or manufacturing line B has deviation management."
            },
            {
              "id": "Rule22",
              "prover9": "(A41 -> (-(A24 | A25) -> A40))",
              "prover9_expression": "(capa_implementation(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
              "natural": "Provided that manufacturing line B has CAPA implementation, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
            },
            {
              "id": "Rule24",
              "prover9": "(A42 -> (-(A24 | A25) -> A40))",
              "prover9_expression": "(deviation_management(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
              "natural": "Under the condition that manufacturing line B has deviation management, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
            }
          ],
          "conclusion": "(-(A24 | A25) -> A40)",
          "natural": "Under the condition that it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B has equipment upgrades."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A24 | A25) -> A40)",
              "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b))",
              "natural": "Under the condition that it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B has equipment upgrades."
            },
            {
              "id": "Rule21",
              "prover9": "(A40 -> A39)",
              "prover9_expression": "(equipment_upgrade(manufacturing_line_b) -> process_improvement(manufacturing_line_b))",
              "natural": "Whenever manufacturing line B has equipment upgrades, manufacturing line B has process improvements."
            }
          ],
          "conclusion": "(-(A24 | A25) -> A39)",
          "natural": "If it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has process improvements."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A24 | A25) -> A39)",
              "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> process_improvement(manufacturing_line_b))",
              "natural": "If it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has process improvements."
            },
            {
              "id": "Rule31",
              "prover9": "(-(A24 | A25) -> -A39)",
              "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> -process_improvement(manufacturing_line_b))",
              "natural": "Whenever it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B does not have process improvements."
            }
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A24 | A25)",
              "prover9_expression": "(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b))",
              "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
            },
            {
              "id": "Rule12",
              "prover9": "(A24 -> (-A22 -> A23))",
              "prover9_expression": "(process_validation(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
              "natural": "If manufacturing line B undergoes process validation, then provided that compound X does not undergo prior art search, compound X receives patent rejection."
            },
            {
              "id": "Rule13",
              "prover9": "(A25 -> (-A22 -> A23))",
              "prover9_expression": "(equipment_qualification(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
              "natural": "Whenever manufacturing line B has equipment qualification, if compound X does not undergo prior art search then compound X receives patent rejection."
            }
          ],
          "conclusion": "(-A22 -> A23)",
          "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-A22 -> A23)",
              "prover9_expression": "(-prior_art_search(compound_x) -> patent_rejection(compound_x))",
              "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
            },
            {
              "id": "Rule42",
              "prover9": "(-A22 -> -A23)",
              "prover9_expression": "(-prior_art_search(compound_x) -> -patent_rejection(compound_x))",
              "natural": "Under the condition that compound X does not undergo prior art search, compound X does not receive patent rejection."
            }
          ],
          "conclusion": "A22",
          "natural": "Compound X undergoes prior art search."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(A22 -> (A21 -> A19))",
              "prover9_expression": "(prior_art_search(compound_x) -> (intellectual_property(compound_x) -> patent_protection(compound_x)))",
              "natural": "Under the condition that compound X undergoes prior art search, if compound X has intellectual property protection then compound X has patent protection."
            },
            {
              "id": "Derived",
              "prover9": "A22",
              "prover9_expression": "prior_art_search(compound_x)",
              "natural": "Compound X undergoes prior art search."
            }
          ],
          "conclusion": "(A21 -> A19)",
          "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
        },
        {
          "step_number": 7,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule10",
              "prover9": "(A20 -> A21)",
              "prover9_expression": "(patent_filing(compound_x) -> intellectual_property(compound_x))",
              "natural": "Provided that compound X has patent filing, it follows that compound X has intellectual property protection."
            },
            {
              "id": "Derived",
              "prover9": "(A21 -> A19)",
              "prover9_expression": "(intellectual_property(compound_x) -> patent_protection(compound_x))",
              "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
            }
          ],
          "conclusion": "(A20 -> A19)",
          "natural": "If compound X has patent filing, then compound X has patent protection."
        },
        {
          "step_number": 8,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule44",
              "prover9": "(-G -> A20)",
              "prover9_expression": "(-profitable_product(compound_x) -> patent_filing(compound_x))",
              "natural": "Whenever compound X is not profitable, compound X has patent filing."
            },
            {
              "id": "Derived",
              "prover9": "(A20 -> A19)",
              "prover9_expression": "(patent_filing(compound_x) -> patent_protection(compound_x))",
              "natural": "If compound X has patent filing, then compound X has patent protection."
            }
          ],
          "conclusion": "(-G -> A19)",
          "natural": "Provided that compound X is not profitable, compound X has patent protection."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A19)",
              "prover9_expression": "(-profitable_product(compound_x) -> patent_protection(compound_x))",
              "natural": "Provided that compound X is not profitable, compound X has patent protection."
            },
            {
              "id": "Fact2",
              "prover9": "-A19",
              "prover9_expression": "-patent_protection(compound_x)",
              "natural": "Compound X does not have patent protection."
            }
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    }
  ]
}